#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16116	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2517	788.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1629	1629	C	1009	C,T	1008,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16116	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2517	788.0	0	HET	.	.	.	A69G,T,C	.	69	69	A	514	514	A	1052	A,G,T,C	801,249,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4104	806.6	0	.	n	.	0	T695C	SNP	695	695	T	1251	1251	C	1001	C,T,A,G	997,1,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4104	806.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1893	1893	A	1088	A	1088	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4104	806.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2527	2527	C	922	C	922	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4104	806.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2601	2601	A	834	A,T,C	831,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4104	806.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3153	3153	C	918	C,A,T,G	914,2,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4104	806.6	0	HET	.	.	.	C2626CGGGGG,CGGGG	.	2626	2626	C	3182	3182	C	922	CGGGGG,CGGGG	678,203	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2260	folP	855	855	100.0	folP.l6.c4.ctg.1	2050	137.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1206	1208	AGC	210;213;213	A;G;C,G	210;213;212,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5270	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3923	167.6	1	SNP	p	S91F	1	.	.	271	273	TTC	831	833	TTC	199;198;198	T,G;T;C	198,1;198;198	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5270	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3923	167.6	1	SNP	p	D95G	1	.	.	283	285	GGC	843	845	GGC	203;204;205	G,T;G,T,C;C	202,1;202,1,1;205	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5270	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3923	167.6	1	SNP	p	G95N	0	.	.	283	285	GGC	843	845	GGC	203;204;205	G,T;G,T,C;C	202,1;202,1,1;205	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2184	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1735	157.0	1	SNP	p	G45D	0	.	.	133	135	GGC	690	692	GGC	239;241;241	G;G;C	239;241;241	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1136	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1403	101.0	0	.	n	.	0	A197.	DEL	197	197	A	773	773	A	222	A	222	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3481	196.6	1	SNP	p	D86N	0	.	.	256	258	GAC	848	850	GAC	258;257;258	G;A,G,C;C,T	258;255,1,1;257,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3481	196.6	1	SNP	p	S87R	1	.	.	259	261	CGT	851	853	CGT	258;257;258	C;G;T	258;257;258	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3481	196.6	1	SNP	p	R87I	0	.	.	259	261	CGT	851	853	CGT	258;257;258	C;G;T	258;257;258	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3481	196.6	1	SNP	p	R87W	0	.	.	259	261	CGT	851	853	CGT	258;257;258	C;G;T	258;257;258	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3481	196.6	1	SNP	p	S88P	0	.	.	262	264	TCC	854	856	TCC	261;260;263	T;C;C	261;260;263	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4406	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3139	175.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1805	1807	GGC	261;262;261	G,T;G;C	259,2;262;261	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1464	1466	GCA	260;262;264	G,A;C;A	259,1;262;264	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1467	1469	ATC	267;262;266	A;T;C	267;262;266	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1479	1481	GTG	268;268;267	G;T,G;G	268;267,1;267	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1479	1481	GTG	268;268;267	G;T,G;G	268;267,1;267	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1983	1985	ACC	250;251;250	A;C;C	250;251;250	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2037	2039	GCG	231;229;226	G;C;G,T	231;229;225,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2037	2039	GCG	231;229;226	G;C;G,T	231;229;225,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2160	2162	AGC	207;206;205	A;G,C;C	207;205,1;205	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2169	2171	GGC	207;210;213	G,C;G;C	206,1;210;213	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4182	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2820	184.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2187	2189	CCG	211;212;211	C,G;C;G,A	210,1;212;210,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5670	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3376	209.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1802	1804	CCG	215;212;213	C,T;C,T;G,T	214,1;211,1;211,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2474	porA	1146	1146	99.91	porA.l6.c30.ctg.1	2315	133.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	862	862	C	194	C	194	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	31;37;39	T,G;T;A	30,1;37;39	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	63;63;63	C;A;T	63;63;63	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	63;63;63	A;G;T	63;63;63	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T;A;C	63;63;63	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;3;3	G;C;A	2;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	3;3;3	G;A;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;5	G;C;C	4;4;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	226	90.27	porB1a.l6.c4.ctg.3	576	23.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	100	94.0	porB1a.l6.c4.ctg.4	182	61.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	75;74;71	A,C;C;G	74,1;74;71	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	332	porB1a	984	100	94.0	porB1a.l6.c4.ctg.4	182	61.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	19;16;12	C;A;A	19;16;12	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	660	662	GAA	263;263;265	G;A,G;A	263;262,1;265	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	948	950	GAT	242;242;241	G,T;A;T	241,1;242;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1071	1073	TCA	264;265;266	T;C;A	264;265;266	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1194	1196	CAT	274;272;270	C;A;T,G	274;272;269,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1200	1202	GTC	266;264;265	G,T;T;C,T	265,1;264;264,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1212	1214	TCT	270;266;266	T,A;C;T	269,1;266;266	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1530	1532	GCA	255;250;250	G,A;C,G;A,C	254,1;249,1;248,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	1	SNP	p	G120K	1	.	.	358	360	AAG	906	908	AAG	236;234;234	A;A;G,T	236;234;233,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	1	SNP	p	D121N	0	.	.	361	363	GAC	909	911	GAC	232;233;234	G;A,C;C	232;232,1;234	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1945	188.0	1	SNP	p	A121D	1	.	.	361	363	GAC	909	911	GAC	232;233;234	G;A,C;C	232;232,1;234	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10210	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5332	238.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1470	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1595	115.0	1	SNP	p	V57M	1	.	.	169	171	ATG	780	782	ATG	247;249;246	A;T;G	247;249;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
